1. Home
  2. AG vs MRUS Comparison

AG vs MRUS Comparison

Compare AG & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AG
  • MRUS
  • Stock Information
  • Founded
  • AG 1979
  • MRUS 2003
  • Country
  • AG Canada
  • MRUS Netherlands
  • Employees
  • AG N/A
  • MRUS N/A
  • Industry
  • AG Precious Metals
  • MRUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • AG Basic Materials
  • MRUS Health Care
  • Exchange
  • AG Nasdaq
  • MRUS Nasdaq
  • Market Cap
  • AG 4.1B
  • MRUS 4.1B
  • IPO Year
  • AG N/A
  • MRUS 2016
  • Fundamental
  • Price
  • AG $8.10
  • MRUS $53.11
  • Analyst Decision
  • AG Buy
  • MRUS Strong Buy
  • Analyst Count
  • AG 2
  • MRUS 12
  • Target Price
  • AG $8.75
  • MRUS $87.92
  • AVG Volume (30 Days)
  • AG 28.4M
  • MRUS 2.0M
  • Earning Date
  • AG 07-31-2025
  • MRUS 07-31-2025
  • Dividend Yield
  • AG 0.24%
  • MRUS N/A
  • EPS Growth
  • AG N/A
  • MRUS N/A
  • EPS
  • AG N/A
  • MRUS N/A
  • Revenue
  • AG $698,532,000.00
  • MRUS $54,732,000.00
  • Revenue This Year
  • AG $68.65
  • MRUS $75.57
  • Revenue Next Year
  • AG $9.36
  • MRUS $31.84
  • P/E Ratio
  • AG N/A
  • MRUS N/A
  • Revenue Growth
  • AG 33.60
  • MRUS 42.77
  • 52 Week Low
  • AG $4.43
  • MRUS $33.19
  • 52 Week High
  • AG $8.70
  • MRUS $62.98
  • Technical
  • Relative Strength Index (RSI)
  • AG 63.69
  • MRUS 53.18
  • Support Level
  • AG $8.10
  • MRUS $52.41
  • Resistance Level
  • AG $8.70
  • MRUS $54.59
  • Average True Range (ATR)
  • AG 0.38
  • MRUS 2.15
  • MACD
  • AG 0.04
  • MRUS -0.77
  • Stochastic Oscillator
  • AG 74.03
  • MRUS 7.62

About AG First Majestic Silver Corp. (Canada)

First Majestic Silver Corp is engaged in the production, development, exploration, and acquisition of mineral properties with a focus on silver and gold production in North America. It owns three producing mines in Mexico consisting of the San Dimas Silver/Gold Mine, the Santa Elena Silver/Gold Mine, and the La Encantada Silver Mine.

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

Share on Social Networks: